Lineage Cell Therapeutics, Inc.
AMEX:LCTX · New York Stock Exchange American
-$0.04 today
Vol 0.85M · Avg 1.19M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+26.12%
Period High
$1.96
Period Low
$0.90
Latest
$1.21
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
RAPT Therapeutics, Inc.
RAPT
$959.26M
Omeros Corporation
NASDAQ:OMER
$748.36M
Neurogene Inc.
NASDAQ:NGNE
$500.92M
Ocugen, Inc.
NASDAQ:OCGN
$426.54M
PureTech Health plc
NASDAQ:PRTC
$421.39M
Autolus Therapeutics plc
NASDAQ:AUTL
$412.12M
Benitec Biopharma Inc.
NASDAQ:BNTC
$318.11M
Fulcrum Therapeutics, Inc.
NASDAQ:FULC
$195.88M
Galectin Therapeutics Inc.
NASDAQ:GALT
$184.16M
ADC Therapeutics S.A.
NYSE:ADCT
$138.00M
What is the latest LCTX filing?
The latest filing shown is 8-K dated Jun 12, 2026.
How many recent filings does LCTX have?
Intrinsic Alpha currently shows 20 recent filings for LCTX.
Explore More
Continue the stock analysis
Jump to another research area for this company.